AOL Money & Finance

Analyst upgrades, downgrades and initiations: DIS, ED, RBS, X ...

More

Analyst upgrades:
  • Barclays believes Disney (NYSE: DIS) is the best positioned company for "media's digital evolution." The firm upgraded shares to Overweight from Underweight and has a $32 target on shares.
  • Oppenheimer upgraded Semtech (NASDAQ: SMTC) to Outperform from Perform after channel checks indicated improved inventory levels, better product mix, and market share gains. The firm set a $20 target on the stock.
  • RBC Capital expects Rigel's (NASDAQ: RIGL) R788 in RA to achieve its primary endpoint in the Phase II trials. Shares were upgraded to Sector Perform from Underperform and the price target was raised to $8 from $6.
  • WebMD (NASDAQ: WBMD) was upgraded to Accumulate from Sell at ThinkEquity.
  • International Game Tech (NYSE: IGT) was raised to Conviction Buy from Neutral at Goldman.
  • Infineon (NYSE: IFX) was lifted at Banc of America/Merrill to Buy from Neutral.
Analyst downgrades:
  • Jefferies downgraded Consolidated Edison (NYSE: ED) to Hold from Buy to reflect lower earnings assumptions. The firm cut its target price on shares to $40.50 from $41.
  • Citigroup downgraded Fifth Third Bancorp (NASDAQ: FITB) to Hold from Buy on valuation following the recent rally and concerns capital may need to be raised following the stress test.
  • Bernstein downgraded Wynn Resorts (NASDAQ: WYNN) to Market Perform from Outperform citing recent share strength. Despite the downgrade, the firm raised its price target on shares to $40 from $30.
  • Intercontinental Exchange (NYSE: ICE) was downgraded to Neutral from Outperform at Credit Suisse.
  • Federal-Mogul (NASDAQ: FDML) was cut to Buy from Conviction Buy at Goldman.
  • Royal Bank of Scotland (NYSE: RBS) was downgraded to Sell from Neutral at UBS.
Analyst initiations:
  • U.S. Steel (NYSE: X) was initiated with a Sell rating and $28.50 target at CLSA.
  • Oxford Industries (NYSE: OXM) was assumed at KeyBanc with a Hold rating.
  • Canaccord initiated EnteroMedics (NASDAQ: ETRM) with a Speculative Buy rating and $6 target.
Symbol Lookup
IndexesChangePrice
DJIA+30.6910,464.40
NASDAQ+6.872,176.05
S&P 500+4.981,110.63

Last updated: November 27, 2009: 02:14 AM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

TheFlyOnTheWall.com Headlines

    BioHealth Investor Headlines

    WalletPop Headlines

    My Portfolios

    Track your stocks here!

    Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

    BloggingStocks Partners

    More from AOL Money & Finance

    WalletPop Headlines